Lumenix announces new partnership to address future pandemic threats in Canada and around the world
May 06 2024 - 6:45PM
Lumenix is proud to announce a new partnership with the PRAIRIE Hub
for Pandemic Preparedness, which received nearly $100 million in
new federal research grants today to conduct world-leading vaccine
and biomanufacturing research and prepare Canada for future health
threats by increasing domestic capacity to produce life-saving
vaccines.
The funding was announced by the Hon. Soraya Martinez Ferrada,
Minister of Tourism and Minister responsible for the Economic
Development Agency of Canada for the Regions of Quebec, as part of
a series of investments totalling nearly $574 million by the
Canada Foundation for Innovation’s Canadian Biomedical Research
Fund and the Biosciences Research Infrastructure Fund in pandemic
preparedness projects at five research hubs across the
country.
“The projects that we’re supporting today will strengthen our
ability to supply medicines, vaccines and therapeutics for the
benefit of Canadians,” Martinez Ferrada says. “These collaborations
between research hubs, post-secondary institutions and research
hospitals will foster innovation across the country. Thanks to the
work of experienced scientists in institutions at the cutting edge
of innovation, Canada will be ready to respond to future health
priorities.”
Lumenix is proud to be working on the “Viral Vector Vaccine
Platforms for Rapid Response to Future Pandemics (3VP)” Project
administered through the PRAIRIE Hub, a multi-disciplinary team
representing the universities of Manitoba, Alberta and Calgary and
the Vaccine and Infectious Disease Organization at the University
of Saskatchewan. The project received $57 million in federal
funding to accelerate the development of next-generation vaccines
and testing of vaccine efficacy and safety while supporting the
training of highly skilled talent in vaccine manufacturing and
testing in Canada.
Lumenix is a leader in building technologies and artificial
intelligence, and its Artificially Intelligent Monitoring System
(AIMS) embodies the most advanced agile perceptual system available
in the world today. Developed by leading clinicians and
engineers at Boston Children’s Hospital, AIMS can anonymously
monitor tasks and activities in three dimensions within the
clinical and operational environment. Leveraging the AIMS platform
technology, Lumenix will play a crucial role in ensuring process
and product consistency while developing optimal standard operating
procedures as the Hub strengthens Canada’s vaccine
bio-manufacturing capacity.
“AIMS was designed to apply the best of robotics engineering,
artificial intelligence and 3D perceptual systems to address some
of the world’s most persistent clinical care and operational
challenges,” said Scott Delaney, Lumenix Chairman and CEO. “Our
partnership with the PRAIRIE Hub underscores our commitment and
vision for the future: to use the potential within AIMS to help
solve global population health challenges, helping our partners
within the public and private sectors in Canada and around the
world elevate standards of health practices, care and
research.”
The funding announced today marks a significant step toward
rebuilding Canada’s biomanufacturing sector, improving Canada’s
pandemic readiness and supporting the innovative and world-leading
scientists who are finding made-in-Canada solutions to global
challenges.
“The future will bring a collection of alternative
vaccines that are best suited for diverse
individuals, and this will require the scale-up of
high-quality standardized vaccine production across many
manufacturing centres worldwide,” says Dr. Maya Shmulevitz, 3VP
Co-Director, Canada Research Chair in Molecular Virology and
Oncotherapy, and professor at the University of Alberta, Department
of Medical Microbiology and Immunology. “We are leveraging the
leading-edge Lumenix AIMS platform technology to rapidly
standardize vaccine manufacturing, unite best
practices and inspire vaccine quality and
safety globally.”
About Lumenix
Lumenix is a leading provider of hardware, software, sensors,
and artificial intelligence currently serving and trusted by
thousands of clients across healthcare, commercial, residential,
industrial and retail sectors in North America. Lumenix is
committed to its vision of providing continuous value creation and
enhanced safety for its partners and clients through the
application of proprietary artificial intelligence, robotics
engineering, interconnectivity, and clean technologies.
For more information contact
info@lumenix.com
About the PRAIRIE Hub
The PRAIRIE Hub for Pandemic Preparedness is one of five
national pandemic preparedness hubs created in 2023
through Stage 1 of the integrated Canadian Biomedical Research
Fund (CBRF) and Biosciences Research Infrastructure Fund
(BRIF) competition.
The PRAIRIE Hub is led by the University of Alberta and includes
the universities of Manitoba, Calgary, Saskatchewan/VIDO
and select other partners across multiple sectors in the Hub
region.
For media inquiries call 613-884-0209